About CAP

Clinical Assistance Programs ("CAP") is a clinical trial management and consulting company based in Framingham, Massachusetts. We provide intelligent, evidence-based development solutions to help design, manage and implement clinical trials of all sizes and levels of complexity. We are known for our ability to eliminate the risk of clinical trial failure due to poor endpoint selection, or inaccurate and/or inconsistent endpoint assessment.

CAP takes pride in the fact that we still answer our phone. At CAP you don't get the office voice mail, you get a person. We manage projects, interact with clients, and respond to emergent situations in real-time with real people. We provide clients with a level of personal service that is unparalled in the industry.

Sharply Focused. Smart.

Our top-of-class clinical experts participate actively and longitudinally in your study providing meaningful guidance support and feedback from start to finish. They design protocols, educate all study team members and trainers, continuously review data, and interact with medical monitors in an effort to provide you with a level of study support and confidence well above industry standards. All of our clinical development projects, large and small, are developed and personally managed by an industry-leading clinical team.

Global Experience.

CAP has been in business over for over a decade and has conducted dozens of studies at all stages of clinical development. Our client list contains the names of many of the largest and most well-respected pharmaceutical and ife science companies in the world. A CRO with active trials in Western Europe, Eastern Europe, Australia, India, the Far East and North America, CAP has global clinical trial experience. We have spent more than a decade building a respected team together with networks of impressive and credible educators and investigators to assure high quality data regardless of venue.

CAP offers clients a deep level expertise borne of years of experience.

*CAP is affiliated with Biomodels, LLC, a preclinical CRO co-owned by Brigham and Women’s Hospital, a Harvard Medical School teaching affiliate.